🇺🇸 FDA
Patent

US 9469878

Methods of treating cancer comprising targeting NQO1

granted A61KA61K31/00A61K31/352

Quick answer

US patent 9469878 (Methods of treating cancer comprising targeting NQO1) held by The Board of Regents of the University of Texas System expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/00, A61K31/352, A61K31/357, A61K31/4025